Reply: Management of De Novo CML and Imatinib-Induced Acute Rhabdomyolysis With the Second-Generation TKI, Dasatinib


Malkan U. Y., GÜNEŞ G., ETGÜL S., Aslan T., Aydin S., HAZNEDAROĞLU İ. C.

ANNALS OF PHARMACOTHERAPY, vol.50, no.4, pp.336, 2016 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Letter
  • Volume: 50 Issue: 4
  • Publication Date: 2016
  • Doi Number: 10.1177/1060028016629981
  • Journal Name: ANNALS OF PHARMACOTHERAPY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.336
  • Hacettepe University Affiliated: Yes